Analytical Data
-
Gene name
LGALS2
- Application
-
Alternative Names
LGALS2;Galectin-2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P17931
-
Expression Region
2-250aa
-
AA Sequence
ADNFSLHDAL SGSGNPNPQG WPGAWGNQPA GAGGYPGASY PGAYPGQAPP GAYPGQAPPG AYPGAPGAYP GAPAPGVYPG PPSGPGAYPS SGQPSATGAY PATGPYGAPA GPLIVPYNLP LPGGVVPRML ITILGTVKPN ANRIALDFQR GNDVAFHFNP RFNENNRRVI VCNTKLDNNW GREERQSVFP FESGKPFKIQ VLVEPDHFKV AVNDAHLLQY NHRVKKLNEI SKLGISGDID LTSASYTMI
-
Molecular Weight
26.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LGALS2, also known as galectin-2, is a member of the galectin family, characterized by its ability to bind β-galactoside sugars. It plays critical roles in various biological processes, including cell adhesion, apoptosis, and immune responses. Research has highlighted LGALS2's involvement in pathological conditions such as cancer, where it is implicated in tumor progression and metastasis, as well as in inflammatory diseases. Given its diverse functions, LGALS2 is a potential biomarker and therapeutic target. Recombinant LGALS2 protein is extensively studied to elucidate its molecular mechanisms and interactions with other proteins and glycoconjugates. The generation of LGALS2 as a recombinant protein allows researchers to perform in-depth functional assays, investigate binding affinities, and explore its role in cellular pathways. This research is crucial for understanding its contribution to disease mechanisms and developing strategies for targeted therapies. The ongoing studies on LGALS2 seek to provide more insights into its potential clinical applications, emphasizing the need for robust recombinant production methods to ensure high purity and functionality of the protein for experimental use.
